Clinical Trials Browser

Phase 1/2 × dostarlimab × 30 days × Clear all

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases, Mouth Neoplasms, Oropharyngeal Neoplasms

Neoplasms